Refractory hyperkalaemia associated with use of epsilon-aminocaproic acid during coronary bypass in a dialysis patient.
Nzerue
Chike Magnus
CM
Falana
Babajide
B
D015119:Aminocaproic Acid / Q000009:adverse effects*; D002125:Calcium Gluconate / Q000627:therapeutic use; D002315:Cardiopulmonary Bypass; D001026:Coronary Artery Bypass; D004562:Electrocardiography; D004573:Electrolytes / Q000097:blood; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D007676:Kidney Failure, Chronic / Q000628:therapy; D008875:Middle Aged; D006435:Renal Dialysis
D004573:Electrolytes; D005343:Fibrinolytic Agents; D002125:Calcium Gluconate; D015119:Aminocaproic Acid